哥倫比亞國家石油
EC
巴西石油公司
PBR
淡水河谷
VALE
Meta Platforms
META
Adobe
ADBE
美股市場個股詳情
ASND Ascendis Pharma A/S
- 137.500
- -2.810-2.00%
收盤價 12/27 16:00 (美東)
- 137.500
- 0.0000.00%
盤後 20:01 (美東)
82.22億總市值-17.68市盈率TTM
141.250最高價137.260最低價16.46萬股成交量139.390今開140.310昨收2275.42萬成交額0.28%換手率虧損市盈率(靜)5979.98萬總股本161.00052周最高-81.07市淨率81.62億流通值111.09052周最低--股息TTM5935.92萬流通股183.980歷史最高--股息率TTM2.84%振幅11.920歷史最低138.224平均價1股每手
關於Ascendis Pharma A/S公司
Ascendis Pharma AS是一家生物製藥公司。該公司利用其 Transcon 技術開發原藥療法，以滿足大型市場未得到滿足的醫療需求。該公司的產品線包括 Transcon 生長激素、Transconpeptides、Transcon PTH、Transcon CNP 等。該公司在北美、中國和歐洲開展業務，大部分收入來自北美。
公司介紹
公司代碼ASND
公司名稱Ascendis Pharma A/S
上市日期2015/01/28
發行價格18.00
成立日期2006
CEOMr. Jan Moller Mikkelsen
所屬市場納斯達克
員工數量879
證券類型存託憑證
ADS轉換比例1.0 : 1.0
年結日12-31
公司地址Tuborg Boulevard 12
城市Hellerup
省份首都地區
國家丹麥
郵編2900
電話45-70-22-22-44
董事高管
- 姓名
- 職務
- 年薪
- Jan Moller Mikkelsen
- President, Chief Executive Officer and Director
- --
- Lotte Sonderbjerg
- Executive Vice President and Chief Administrative Officer
- --
- Camilla Harder Hartvig
- Executive Vice President and Global Chief Commercial Officer
- --
- Michael Wolff Jensen
- Executive Vice President and Chief Legal Officer
- --
- Scott T Smith
- Executive Vice President and Chief Financial Officer
- --
- Peter Rasmussen
- Vice President, Finance and Principal Accounting Officer
- --
- Flemming Steen Jensen
- Executive Vice President, Product Supply and Quality
- --
- Dr. Kennett Sprogoe, PhD
- Executive Vice President and Head of Innovation and Research
- --
- Dr. Stina Singel, M.D.
- Executive Vice President and Head of Clinical Development, Oncology
- --
- Dr. Albert Cha, M.D.,PhD
- Chairman of the Board
- --
- Lars Holtug
- Independent Director
- --
- William Carl Fairey
- Independent Director
- --
- Lisa Bright
- Independent Director
- --
- Siham Imani
- Independent Director
- --